概述

  • 产品名称Capsazepine
  • 描述
    VR1 antagonist
  • 生物学描述VR1 vanilloid receptor antagonist (IC50 = 562 nM). Analgesic in vivo.
  • 纯度> 99%

性能

    Capsazepine (ab120025)参考文献

    This product has been referenced in:
    • Menéndez L  et al. Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice. Neurosci Lett 393:70-3 (2006). Read more (PubMed: 16243435) »
    • Seabrook GR  et al. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin. J Pharmacol Exp Ther 303:1052-60 (2002). Read more (PubMed: 12438527) »
    • Walpole CS  et al. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. J Med Chem 37:1942-54 (1994). Read more (PubMed: 8027976) »
    • Perkins MN & Campbell EA Capsazepine reversal of the antinociceptive action of capsaicin in vivo. Br J Pharmacol 107:329-33 (1992). Read more (PubMed: 1422585) »

    See all 6 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120025.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"